An Update on Kleine-Levin Syndrome.

HLA-type Hyperphagia Hypersexuality Hypersomnia Hypersomnolence Sleepiness

Journal

Current sleep medicine reports
ISSN: 2198-6401
Titre abrégé: Curr Sleep Med Rep
Pays: Switzerland
ID NLM: 101649332

Informations de publication

Date de publication:
2023
Historique:
accepted: 30 11 2022
pubmed: 3 1 2023
medline: 3 1 2023
entrez: 2 1 2023
Statut: ppublish

Résumé

Kleine-Levin syndrome (KLS) is a rare relapsing-remitting sleep disorder distinguished by recurrent periods of severe hypersomnia accompanied by cognitive, mood, and behavioral changes. This review focuses mainly on the most recent developments and articles concerning this illness in the preceding five years while attempting to provide a basic overview of KLS. Genetic links were reported in some patients with KLS, like variation in TRANK1 in a worldwide case-control genome-wide association in patients with KLS, in addition to several uncommon variations in the LMOD3 gene, some of which are likely to be pathogenic, discovered by linkage analysis and exome sequencing in a sizable Saudi Arabian family with KLS and a European cohort of KLS patients. Additionally, recent data indicate that the amplitude of the circadian active/rest cycles significantly decreased during hypersomnia attacks, but during asymptomatic periods, it did not differ significantly from the controls. Moreover, patients with KLS are at a higher risk of developing emerging psychiatric disorders during follow-up. Recent data also points to possible discoveries of diagnostic-potential dysregulated proteomic patterns in KLS. Finally, new data suggest that functional imaging studies are often abnormal in KLS both during and between episodes. KLS is an uncommon, severe, and uniform illness. When it comes to the diagnosis and treatment of KLS, these characteristics offer both opportunities and challenges. Over the past five years, some promising work has appeared in genetics, functional imaging, and biomarker identification; nevertheless, these areas still need more focus to advance the detection and treatment of patients suffering from KLS.

Identifiants

pubmed: 36590182
doi: 10.1007/s40675-022-00246-1
pii: 246
pmc: PMC9793345
doi:

Types de publication

Journal Article Review

Langues

eng

Pagination

35-44

Informations de copyright

© The Author(s), under exclusive licence to Springer Nature Switzerland AG 2022, Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.

Déclaration de conflit d'intérêts

Competing interestsShaden O. Qasrawi and Ahmed S. BaHammam declare no conflict of interest.

Auteurs

Shaden O Qasrawi (SO)

Sleep Disorders Unit, Kingdom Hospital, Riyadh, Saudi Arabia.

Ahmed S BaHammam (AS)

Department of Medicine, University Sleep Disorders Center and Pulmonary Service, King Saud University, Riyadh, Saudi Arabia.
The Strategic Technologies Program of the National Plan for Sciences and Technology and Innovation in the Kingdom of Saudi, Arabia (08 MED511 02), Riyadh, Saudi Arabia.

Classifications MeSH